WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

KOSDAQ:330350 Revenue

WITHUS PHARMACEUTICAL Co.,LTD. had revenue of 28.22B KRW in the quarter ending March 31, 2026, with 9.50% growth. This brings the company's revenue in the last twelve months to 108.89B, up 6.23% year-over-year. In the year 2025, WITHUS PHARMACEUTICAL Co.,LTD. had annual revenue of 106.44B with 3.62% growth.

• Revenue (ttm): 108.89B
• Revenue Growth: +6.23%
• P/S Ratio: 1.07
• Revenue / Employee: 899.93M
• Employees: 121
• Market Cap: 116.97B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	106.44B	3.72B	3.62%
Dec 31, 2024	102.72B	22.60B	28.21%
Dec 31, 2023	80.12B	15.44B	23.87%
Dec 31, 2022	64.68B	7.26B	12.65%
Dec 31, 2021	57.42B	4.01B	7.51%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error